FDA Inspection
Steri-Pharma, LLCSteri-Pharma, LLC – FDA Inspection, Oct 4, 2022
Record Details
This FDA Inspection record concerns Steri-Pharma, LLC, with an inspection on October 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Steri-Pharma, LLC
- Inspection Date
- October 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 583592eb-4663-45c6-aa76-e0c1546a0e87
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1180892
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Steri-Pharma, LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 8, 2025 | OAI | New York District Office | Drug Quality Assurance |
| March 24, 2017 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| October 10, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2014 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 20, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Steri-Pharma, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.